产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 2mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 10g | 98% | 现货 | |||
| 25g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 2mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 | |||
| 10g | 98% | 现货 | |||
| 25g | 98% | 现货 |
CAS No. |
417716-92-8 |
|---|---|
中文名称 |
4-(3-氯-4-(3-环丙基脲基)苯氧基)-7-甲氧基喹啉-6-甲酰胺 |
英文名称 |
4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
别名 |
LENVATINIB [MI] | UNII-EE083865G2 | AS-16203 | LEV | NSC800781 | NSC-800781 | DB09078 | AKOS021983298 | LENVATINIB [INN] | AKOS015838040 | BCP9000633 | DTXSID30182868 | 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
标准英文名 |
4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide |
分子式 |
C21H19ClN4O4 |
分子量 |
426.86 |
精确分子量 |
426.11 |
SMILES |
O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC4CC4)=O)C(Cl)=C3)C2=C1)N |
标准SMILES |
COC1C=C2N=CC=C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)C2=CC=1C(N)=O |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
WOSKHXYHFSIKNG-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Inert atmosphere,Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|